306 related articles for article (PubMed ID: 17540032)
21. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
[TBL] [Abstract][Full Text] [Related]
22. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
23. Current Approaches to Diagnosis and Treatment of Ductal Carcinoma In Situ and Future Directions.
Ryan R; Tawfik O; Jensen RA; Anant S
Prog Mol Biol Transl Sci; 2017; 151():33-80. PubMed ID: 29096897
[TBL] [Abstract][Full Text] [Related]
24. [Current knowledge of ductal carcinoma in situ].
Böhm J; Zikán M
Ceska Gynekol; 2009 Oct; 74(5):339-47. PubMed ID: 20063837
[TBL] [Abstract][Full Text] [Related]
25. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
27. [Differential atypical ductal hyperplasia/DCIS/invasive carcinoma diagnosis and significance of micrometastases].
Stosiek P
Zentralbl Chir; 1998; 123 Suppl 5():13. PubMed ID: 10063563
[TBL] [Abstract][Full Text] [Related]
28. Premalignant and malignant disease of the breast: the roles of the pathologist.
Page DL; Jensen RA; Simpson JF
Mod Pathol; 1998 Feb; 11(2):120-8. PubMed ID: 9504682
[TBL] [Abstract][Full Text] [Related]
29. [Chinese expert consensus on the diagnosis and treatment of breast carcinoma in situ].
Sun Q; Xu BH; Shao ZM;
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):942-947. PubMed ID: 27998472
[TBL] [Abstract][Full Text] [Related]
30. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?
McGhan LJ; Pockaj BA; Wasif N; Giurescu ME; McCullough AE; Gray RJ
Ann Surg Oncol; 2012 Oct; 19(10):3264-9. PubMed ID: 22878619
[TBL] [Abstract][Full Text] [Related]
31. Definition of precancerous and high-risk mammary lesions.
Bégin LR
Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
[TBL] [Abstract][Full Text] [Related]
32. In vivo cell kinetics in breast carcinogenesis.
Bai M; Agnantis NJ; Kamina S; Demou A; Zagorianakou P; Katsaraki A; Kanavaros P
Breast Cancer Res; 2001; 3(4):276-83. PubMed ID: 11434879
[TBL] [Abstract][Full Text] [Related]
33. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers.
Desouki MM; Li Z; Hameed O; Fadare O; Zhao C
Hum Pathol; 2013 Sep; 44(9):1877-81. PubMed ID: 23656973
[TBL] [Abstract][Full Text] [Related]
34. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
35. [Noninvasive breast carcinomas: anatomicopathological, diagnostic and therapeutic findings].
Calabrese L
Acta Biomed Ateneo Parmense; 1998; 69(3-4):113-21. PubMed ID: 10503071
[TBL] [Abstract][Full Text] [Related]
36. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of HSP90 in the continuum of breast ductal and lobular lesions.
Zagouri F; Sergentanis TN; Provatopoulou X; Kalogera E; Chrysikos D; Lymperi M; Papadimitriou CA; Zografos E; Bletsa G; Kalles VS; Zografos GC; Gounaris A
In Vivo; 2011; 25(4):669-72. PubMed ID: 21709012
[TBL] [Abstract][Full Text] [Related]
38. Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.
Gradishar WJ; Anderson BO; Balassanian R; Blair SL; Burstein HJ; Cyr A; Elias AD; Farrar WB; Forero A; Giordano SH; Goetz MP; Goldstein LJ; Isakoff SJ; Lyons J; Marcom PK; Mayer IA; McCormick B; Moran MS; O'Regan RM; Patel SA; Pierce LJ; Reed EC; Salerno KE; Schwartzberg LS; Sitapati A; Smith KL; Smith ML; Soliman H; Somlo G; Telli ML; Ward JH; Kumar R; Shead DA
J Natl Compr Canc Netw; 2018 Mar; 16(3):310-320. PubMed ID: 29523670
[TBL] [Abstract][Full Text] [Related]
39. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.
Omi Y; Yamamoto T; Okamoto T; Obara T; Kobayashi M
Histol Histopathol; 2011 Jan; 26(1):79-86. PubMed ID: 21117029
[TBL] [Abstract][Full Text] [Related]
40. The diagnosis and management of pre-invasive breast disease--current challenges, future hopes.
Lakhani SR
Breast Cancer Res; 2003; 5(5):248-9. PubMed ID: 12927033
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
